Vitamin D metabolites in spasmophilia

Biomed Pharmacother. 1990;44(9):479-82. doi: 10.1016/0753-3322(90)90209-r.

Abstract

The comparison of 20 untreated spasmophilic patients (2 men, 18 women) with 25 healthy subjects revealed no significant differences in vitamin D metabolite plasma levels or in other laboratory indexes of calcium metabolism except for ionized and cytosolic free calcium levels which were lower in the former group (P less than 0.01; P less than 0.001). After 3 months treatment with calcitonin and 25-hydroxyvitamin D there was a clear improvement in patient symptoms, no significant modification of 1,25-dihydroxyvitamin D levels and significant increases in 25-hydroxyvitamin D, cytosolic free calcium and urinary calcium (P less than 0.001, P less than 0.001 and P less than 0.01, respectively). We conclude that high plasma levels of 25-hydroxyvitamin D play an important role in restoring normal cytosolic free calcium levels and reducing clinical manifestations in spasmophilia.

Publication types

  • Comparative Study

MeSH terms

  • Adult
  • Aged
  • Calcifediol / blood
  • Calcifediol / therapeutic use
  • Calcitonin / therapeutic use
  • Calcium / blood
  • Calcium / urine
  • Female
  • Humans
  • Male
  • Middle Aged
  • Tetany / drug therapy
  • Tetany / metabolism*
  • Vitamin D / metabolism*

Substances

  • Vitamin D
  • Calcitonin
  • Calcifediol
  • Calcium